Is there pseudoprogression in secondary glioblastomas? - Wikidata - wikimedia - TriplyDB

Is there pseudoprogression in secondary glioblastomas?

Is there pseudoprogression in secondary glioblastomas?

http://www.wikidata.org/entity/Q35146128

about

Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?Radio-chemotherapy improves survival in IDH-mutant, 1p/19q non-codeleted secondary high-grade astrocytoma patients.Pseudoprogression after glioma therapy: an update.

P2860

Q30937034-5B5AA042-BE73-4B18-8CC6-A4BFA2879D45 Q40879813-165C5B15-A7EE-46AD-968B-8EBF846039B5 Q48130815-D4768BDA-16C2-4071-A9DC-7642B6629B64

P2860

Is there pseudoprogression in secondary glioblastomas?

http://www.wikidata.org/entity/Q35146128

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Is there pseudoprogression in secondary glioblastomas?

@ast

Is there pseudoprogression in secondary glioblastomas?

@en

type

label

Is there pseudoprogression in secondary glioblastomas?

@ast

Is there pseudoprogression in secondary glioblastomas?

@en

prefLabel

Is there pseudoprogression in secondary glioblastomas?

@ast

Is there pseudoprogression in secondary glioblastomas?

@en

P1433

Q35146128-3FD5AD45-2B2F-4333-9C72-D13DFB82CB0C

P1476

Q35146128-6EBA4913-E34E-44DF-B0B9-3F9F7F180F6D

P2093

Q35146128-1FB9F076-59BF-425E-B5B1-8D35BC3C1572

Q35146128-3CAD0C8A-CA58-4D10-BD54-EB1E2C1776D3

Q35146128-40AE4323-90EB-47BD-A49E-2A6F4E87315E

Q35146128-712CBFE6-F1F2-4A60-AE55-23D940E441B9

Q35146128-89107F34-F373-4FDE-8736-6A11FA638F28

Q35146128-B51C72AB-C18E-449E-B848-EDC5181C8420

Q35146128-BAFEBACE-A07A-438D-BBA9-5C34DF76E663

Q35146128-E586193D-F0C5-4E97-821B-FCB464DCEAE0

P2860

Q35146128-01724B3E-F5F9-46B8-A79F-2694509327E0

Q35146128-04FF0225-D51A-4BF7-A352-1BDD4E9C491D

Q35146128-0E5EF5A3-A365-43BD-8B93-AD6BE9E8F583

Q35146128-250A3BC0-4601-4C6B-8E48-43C3C1AE85E4

Q35146128-313E2C19-117E-48B5-8EB4-AF1B4FCE2FC3

Q35146128-34DE73DC-60CB-4919-B0EE-C2DDEF213DC0

Q35146128-3AF8D29F-B8D2-43B5-9004-2FB0D0F5681A

Q35146128-3FFB938E-003A-4774-A02D-5F7D3F1BECD7

Q35146128-40BCF23A-EC0F-4B2D-970D-D284E9134008

Q35146128-42172340-20A6-4868-8567-F4A1BB098CD3

P304

Q35146128-C441A0AE-354F-4D7F-BC8F-453588DD7C55

P31

Q35146128-DE1AFD4B-6F62-43D6-8EE7-819911935923

P356

Q35146128-4DFCF7D4-01F1-492E-B513-D60F53A9C488

P407

Q35146128-A82B42FC-2B18-4F0C-A322-ECFFA085F385

P433

Q35146128-7AAD4C36-2484-4D76-A904-BBD80364D5E5

P478

Q35146128-21F69E79-7305-44DE-AA3E-B72D4AE19694

P50

Q35146128-692CAC5F-AC8B-4D07-953F-09E8707F2B49

P577

Q35146128-0C1CC874-DF5D-416C-871F-733174F99583

P5875

Q35146128-F4AD870E-23FB-4DAB-9752-14406E329238

P698

Q35146128-B5BE1B64-47E3-46CD-8698-58F00EFF1FFA

P932

Q35146128-297153B5-F626-48EE-AEA1-0F935EF2272C

P356

J.IJROBP.2013.09.036

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Is there pseudoprogression in secondary glioblastomas?

@en

P2093

Arnab Chakravarti

http://www.w3.org/2001/XMLSchema#string

Dietmar Krex

http://www.w3.org/2001/XMLSchema#string

Gabriele Schackert

http://www.w3.org/2001/XMLSchema#string

Jana Cerhova

http://www.w3.org/2001/XMLSchema#string

Kathrin D Geiger

http://www.w3.org/2001/XMLSchema#string

Kay Engellandt

http://www.w3.org/2001/XMLSchema#string

Rüdiger von Kummer

http://www.w3.org/2001/XMLSchema#string

Tim Lautenschlaeger

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.

Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients.

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

Radiation dose-volume effects in the brain.

Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas

The definition of primary and secondary glioblastoma.

IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy.

P304

1094-1099

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2013.09.036

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Tareq A Juratli

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258851871

http://www.w3.org/2001/XMLSchema#string

P698

24267971

http://www.w3.org/2001/XMLSchema#string

P932

4349215

http://www.w3.org/2001/XMLSchema#string